SLAMF1 and central nervous system cancer: A paper has reported that the nSLAMF1 isoform is the main SLAMF1 isoform in glioma cells and suggested that SLAMF1 expression in the central nervous system (CNS) tumors can serve as a new diagnostic marker as well as a potential target for innovative therapeutic approaches in the future (128).